Plant ID: NPO11329
Plant Latin Name: Echinops grijsii
Taxonomy Genus: Echinops
Taxonomy Family: Asteraceae
NCBI TaxonomyDB:
1804979
Plant-of-the-World-Online:
202515-1
Taiwan; China
FFAR1; FFAR4; | |
PPARD; PPARA; PPARG; | |
NR1H4; | |
ALOX15; HPGD; | |
TLR2; | |
FABP3; FABP2; FABP4; LMNA; FABP5; |
Cytochrome P450 Enzymes: |
---|
Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|
Enzyme_unclassified | ALOX15 | Arachidonate 15-lipoxygenase | P16050 | CHEMBL2903 |
Enzyme_unclassified | HPGD | 15-hydroxyprostaglandin dehydrogenase [NAD+] | P15428 | CHEMBL1293255 |
Nuclear hormone receptor subfamily 1 group C | PPARD | Peroxisome proliferator-activated receptor delta | Q03181 | CHEMBL3979 |
Nuclear hormone receptor subfamily 1 group C | PPARA | Peroxisome proliferator-activated receptor alpha | Q07869 | CHEMBL239 |
Nuclear hormone receptor subfamily 1 group C | PPARG | Peroxisome proliferator-activated receptor gamma | P37231 | CHEMBL235 |
Nuclear hormone receptor subfamily 1 group H | NR1H4 | Bile acid receptor FXR | Q96RI1 | CHEMBL2047 |
Small molecule receptor (family A GPCR) | FFAR1 | Free fatty acid receptor 1 | O14842 | CHEMBL4422 |
Small molecule receptor (family A GPCR) | FFAR4 | G-protein coupled receptor 120 | Q5NUL3 | CHEMBL5339 |
Toll-like and Il-1 receptors | TLR2 | Toll-like receptor 2 | O60603 | CHEMBL4163 |
Unclassified | FABP3 | Fatty acid binding protein muscle | P05413 | CHEMBL3344 |
Unclassified | FABP2 | Fatty acid binding protein intestinal | P12104 | CHEMBL4879 |
Unclassified | FABP4 | Fatty acid binding protein adipocyte | P15090 | CHEMBL2083 |
Unclassified | LMNA | Prelamin-A/C | P02545 | CHEMBL1293235 |
Unclassified | FABP5 | Fatty acid binding protein epidermal | Q01469 | CHEMBL3674 |
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
BP | GO:0050896; response to stimulus | GO:0070542; response to fatty acid | 2.087E-09 | 5.238E-06 | FABP3, FFAR1, NR1H4, PPARG, TLR2 |
BP | GO:0008152; metabolic process | GO:0019433; triglyceride catabolic process | 2.165E-09 | 5.238E-06 | FABP2, FABP3, FABP4, FABP5 |
BP | GO:0050896; response to stimulus | GO:0050728; negative regulation of inflammatory response | 1.314E-08 | 1.908E-05 | FFAR4, NR1H4, PPARA, PPARD, PPARG |
MF | GO:0140110; transcription regulator activity | GO:0004879; nuclear receptor activity | 3.590E-08 | 3.445E-05 | NR1H4, PPARA, PPARD, PPARG |
MF | GO:0060089; molecular transducer activity | GO:0003707; steroid hormone receptor activity | 7.680E-08 | 6.471E-05 | NR1H4, PPARA, PPARD, PPARG |
BP | GO:0051179; localization | GO:0015908; fatty acid transport | 1.289E-07 | 9.356E-05 | FABP3, PPARA, PPARD, PPARG |
BP | GO:0065007; biological regulation | GO:0055088; lipid homeostasis | 9.537E-07 | 5.192E-04 | FABP3, FABP4, NR1H4, PPARG |
BP | GO:0009987; cellular process | GO:0043401; steroid hormone mediated signaling pathway | 1.861E-06 | 8.442E-04 | NR1H4, PPARA, PPARD, PPARG |
BP | GO:0050896; response to stimulus | GO:0032868; response to insulin | 2.431E-06 | 9.986E-04 | FABP3, PPARA, PPARG, TLR2 |
MF | Unclassified; | GO:0004872; receptor activity | 3.348E-06 | 1.326E-03 | FFAR1, FFAR4, HPGD, NR1H4, PPARA, PPARD, PPARG, TLR2 |
BP | GO:0008152; metabolic process | GO:0006367; transcription initiation from RNA polymerase II promoter | 4.254E-06 | 1.597E-03 | NR1H4, PPARA, PPARD, PPARG |
BP | GO:0051179; localization | GO:0010891; negative regulation of sequestering of triglyceride | 4.872E-06 | 1.768E-03 | PPARA, PPARG |
BP | GO:0009987; cellular process | GO:0030522; intracellular receptor signaling pathway | 6.070E-06 | 2.132E-03 | NR1H4, PPARA, PPARD, PPARG |
BP | GO:0051179; localization | GO:0010887; negative regulation of cholesterol storage | 7.305E-06 | 2.272E-03 | PPARA, PPARG |
BP | GO:0008152; metabolic process | GO:0010871; negative regulation of receptor biosynthetic process | 7.305E-06 | 2.272E-03 | PPARA, PPARG |
BP | GO:0008152; metabolic process | GO:2001300; lipoxin metabolic process | 7.305E-06 | 2.272E-03 | ALOX15, HPGD |
MF | GO:0005488; binding | GO:0050543; icosatetraenoic acid binding | 7.305E-06 | 2.272E-03 | FABP3, PPARG |
BP | GO:0023052; signaling | GO:0032024; positive regulation of insulin secretion | 1.477E-05 | 3.876E-03 | FFAR1, NR1H4, PPARD |
BP | GO:0008152; metabolic process | GO:0071073; positive regulation of phospholipid biosynthetic process | 1.751E-05 | 4.486E-03 | FABP3, NR1H4 |
BP | GO:0050896; response to stimulus | GO:0042060; wound healing | 2.148E-05 | 5.315E-03 | ALOX15, PPARA, PPARD |
MF | GO:0060089; molecular transducer activity | GO:0004955; prostaglandin receptor activity | 2.188E-05 | 5.353E-03 | HPGD, PPARG |
BP | GO:0008152; metabolic process | GO:1902894; negative regulation of pri-miRNA transcription from RNA polymerase II promoter | 2.673E-05 | 6.134E-03 | PPARA, PPARD |
BP | GO:0050896; response to stimulus | GO:0001666; response to hypoxia | 2.844E-05 | 6.323E-03 | LMNA, PPARA, PPARD, TLR2 |
BP | GO:0009987; cellular process | GO:0050872; white fat cell differentiation | 3.788E-05 | 7.708E-03 | FABP4, PPARG |
BP | GO:0009987; cellular process | GO:0010745; negative regulation of macrophage derived foam cell differentiation | 3.788E-05 | 7.708E-03 | PPARA, PPARG |
BP | GO:0008152; metabolic process | GO:0046321; positive regulation of fatty acid oxidation | 4.417E-05 | 8.824E-03 | PPARA, PPARG |
BP | GO:0008152; metabolic process | GO:0032966; negative regulation of collagen biosynthetic process | 4.417E-05 | 8.824E-03 | PPARD, PPARG |
MF | GO:0005488; binding | GO:0046965; retinoid X receptor binding | 5.095E-05 | 9.725E-03 | NR1H4, PPARG |
Pathway Category Top Level | Pathway Category Second Level | Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|---|
09150 Organismal Systems | 09152 Endocrine system | hsa03320 | PPAR signaling pathway | 1.432E-14 | 6.301E-13 | FABP2, FABP3, FABP4, FABP5, PPARG, PPARA, PPARD |
09150 Organismal Systems | 09152 Endocrine system | hsa04923 | Regulation of lipolysis in adipocytes | 3.851E-02 | 1.220E-01 | FABP4 |
09160 Human Diseases | 09167 Infectious diseases | hsa05134 | Legionellosis | 3.783E-02 | 1.220E-01 | TLR2 |
09100 Metabolism | 09103 Lipid metabolism | hsa00590 | Arachidonic acid metabolism | 4.255E-02 | 1.220E-01 | ALOX15 |
09160 Human Diseases | 09162 Immune diseases | hsa05321 | Inflammatory bowel disease (IBD) | 4.457E-02 | 1.220E-01 | TLR2 |
09150 Organismal Systems | 09152 Endocrine system | hsa04920 | Adipocytokine signaling pathway | 4.792E-02 | 1.220E-01 | PPARA |
09160 Human Diseases | 09167 Infectious diseases | hsa05140 | Leishmaniasis | 4.992E-02 | 1.220E-01 | TLR2 |
09150 Organismal Systems | 09158 Development | hsa04380 | Osteoclast differentiation | 8.857E-02 | 1.220E-01 | PPARG |
09140 Cellular Processes | 09143 Cell growth and death | hsa04210 | Apoptosis | 9.369E-02 | 1.220E-01 | LMNA |
09160 Human Diseases | 09167 Infectious diseases | hsa05160 | Hepatitis C | 8.921E-02 | 1.220E-01 | PPARA |
ICD10 Disease Category | Disease Name | ICD10 Code | Associated Disease Targets (Association Ref: TTD database) |
---|---|---|---|
E00-E89: Endocrine, nutritional and metabolic diseases | Non-insulin dependent diabetes | E11.9 | FFAR1; |
E00-E89: Endocrine, nutritional and metabolic diseases | Type 2 diabetes | E11 | FFAR1; |
E00-E89: Endocrine, nutritional and metabolic diseases | Diabetes | E23.2, N25.1 | FFAR1; |